skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 13
Patent #:
5102783
Issue Dt:
04/07/1992
Application #:
07464428
Filing Dt:
01/12/1990
Inventors:
STANLEY J. ALKEMADE, ANDRE PALASZ, REUBEN J. MAPLETOFT
Title:
COMPOSITION AND METHOD FOR CULTURING AND FREEZING CELLS AND TISSUES
Assignment: 1
Reel/Frame:
005688/0254Recorded: 05/01/1991Pages: 3
Conveyance:
NUNC PRO TUNC ASSIGNMENT (SEE DOCUMENT FOR DETAILS).
Assignor:
PALASZ, ANDRE
Exec Dt:
01/12/1990
Assignee:
VETREPHARM, INC.
69 BESSEMER RD., UNIT 27
A CORP. OF CANADA
LONDON, ONTARIO, CANADA N6E 2V6
Correspondent:
JONES, ASKEW & LUNSFORD
P.O. BOX 56527
ATLANTA, GA 30343-0527
Assignment: 2
Reel/Frame:
005688/0257Recorded: 05/01/1991Pages: 3
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST.
Assignor:
MAPLETOFT, REUBEN J.
Exec Dt:
01/12/1990
Assignee:
VETREPHARM, INC.
69 BESSEMER RD., UNIT 27
A CORP. OF CANADA
LONDON, ONTARIO, CANADA N6E 2V6
Correspondent:
JONES, ASKEW & LUNSFORD
P.O. BOX 56527
ATLANTA, GA 30343-0527
Assignment: 3
Reel/Frame:
006072/0890Recorded: 04/08/1992Pages: 3
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST.
Assignor:
ALKEMADE, STANLEY J.
Exec Dt:
01/12/1990
Assignee:
VETREPHARM, INC. A CORPORATION OF CANADA
69 BESSEMER ROAD, UNIT 27
LONDON, ONTARIO, CANADA N6E 2V6
Correspondent:
JAMES DEAN JOHNSON, ESQ.
JONES, ASKEW & LUNSFORD
191 PEACHTREE ST., N.E., 37TH FLOOR
ATLANTA, GEORGIA 30303-1769
Assignment: 4
Reel/Frame:
008268/0317Recorded: 12/13/1996Pages: 11
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
VETREPHARM INC.
Exec Dt:
09/19/1996
VETREPHARM RESEARCH INC.
Exec Dt:
09/19/1996
Assignees:
SNIDER FINANCIAL GROUP INC., THE
SUITE 550
1881 YONGE STREET
TORONTO, ONTARIO, CANADA M4S 3
PARTICIPATION HOLDINGS LIMITED
SUITE 550
2 ST. CLAIR AVENUE EAST, SUITE 1100
TORONTO, ONTARIO, CANADA M4T2T
Correspondent:
GOWLING, STRATHY & HENDERSON
JOHN R. RUDOLPH
50 QUEEN STREET NORTH
SUITE 1020
KITCHENER, ONTARIO N2H 6M2
Assignment: 5
Reel/Frame:
015279/0794Recorded: 10/25/2004Pages: 10
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
THE SNIDER FINANCIAL GROUP, INC.
Exec Dt:
09/19/1996
PARTICIPATION HOLDINGS LIMITED
Exec Dt:
09/19/1996
Assignee:
VETREPHARM INC.
383 SOVEREIGN RD.
LONDON, ONTARIO, CANADA N6M 1A3
Correspondent:
BERESKIN & PARR
ANDREW MCINTOSH
40 KING STREET WEST
TORONTO, ON, CAX M5H 3Y2
Assignment: 6
Reel/Frame:
015279/0778Recorded: 10/25/2004Pages: 16
Conveyance:
ARTICLES OF AMALGAMATION
Assignor:
VETREPHARM INC.
Exec Dt:
07/01/1998
Assignee:
VETREPHARM INVESTMENTS HOLDINGS INC.
383 SOVEREIGN RD.
LONDON, ONTARIO, CANADA N6M 1A3
Correspondent:
BERESKIN & PARR
ANDREW MCINTOSH
40 KING STREET WEST
TORONTO, ONTARIO, CANADA
M5H 3Y2
Assignment: 7
Reel/Frame:
015279/0772Recorded: 10/25/2004Pages: 3
Conveyance:
CHANGE OF NAME (SEE DOCUMENT FOR DETAILS).
Assignor:
VETREPHARM INVESTMENTS HOLDINGS INC.
Exec Dt:
07/02/1998
Assignee:
RENAISSANCE LIFE SCIENCES INC.
383 SOVEREIGN RD.
LONDON, ONTARIO, CANADA N6M 1A3
Correspondent:
BERESKIN & PARR
ANDREW MCINTOSH
40 KING STREET WEST
TORONTO, ONTARIO, CANADA
M5H 3Y2
Assignment: 8
Reel/Frame:
015279/0775Recorded: 10/25/2004Pages: 3
Conveyance:
ARTICLES OF AMALGAMATION
Assignor:
RENAISSANCE LIFE SCIENCES INC.
Exec Dt:
09/01/1999
Assignee:
BIONICHE LIFE SCIENCES INC.
BOX 1570
BELLEVILLE, ONTARIO, CANADA K8N 5J2
Correspondent:
BERESKIN & PATT
40 KING STREET WEST
TORONTO, ONTARIO, CANADA M5H 3Y2
Assignment: 9
Reel/Frame:
014438/0431Recorded: 09/02/2003Pages: 6
Conveyance:
SECURITY AGREEMENT
Assignor:
BIONICHE LIFE SCIENCES INC.
Exec Dt:
05/23/2003
Assignee:
MANUFACTURERS LIFE INSURANCE COMPANY, THE
200 BLOOR STREET EAST NT-6
TORONTO, ONTARIO, CANADA M4W 1E5
Correspondent:
KILPATRICK STOCKTON LLP
JOHN S. PRATT
1100 PEACHTREE STREET
SUITE 2800
ATLANTA, GA 30309-4530
Assignment: 10
Reel/Frame:
016891/0185Recorded: 12/14/2005Pages: 11
Conveyance:
RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS).
Assignors:
BUSINESS DEVELOPMENT BANK OF CANADA
Exec Dt:
12/02/2005
FCC VENTURES, A DIVISION OF FARM CREDIT CANADA
Exec Dt:
12/02/2005
THE MANUFACTURERS LIFE INSURANCE COMPANY
Exec Dt:
12/02/2005
Assignee:
BIONICHE LIFE SCIENCES INC.
231 DUNDAS STREET EAST
BELLEVILLE, ONTARIO K8N1E2
Correspondent:
NANCY H. LUTZ
3050 K STREET NW
COLLIER SHANNON SCOTT, PLLC, SUITE 400
WASHINGTON, DC 20007
Assignment: 11
Reel/Frame:
016891/0196Recorded: 12/14/2005Pages: 22
Conveyance:
SECURITY AGREEMENT
Assignor:
BIONICHE LIFE SCIENCES INC.
Exec Dt:
12/02/2005
Assignee:
LAURUS MASTER FUND, LTD.
825 3RD AVENUE
14TH FLOOR, C/O LAURUS CAPITAL MANAGEMENT
NEW YORK, NEW YORK 10022
Correspondent:
NANCY H. LUTZ
3050 K STREET NW
COLLIER SHANNON SCOTT, PLLC, SUITE 400
WASHINGTON, DC 20007
Assignment: 12
Reel/Frame:
023438/0096Recorded: 10/28/2009Pages: 13
Conveyance:
RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS).
Assignors:
LAURUS MASTER FUND, LTD., AGENT
Exec Dt:
07/14/2009
VALENS U.S. SPV I, LLC C/O VALENS CAPITAL MANAGEMENT, LLC
Exec Dt:
07/14/2009
Assignee:
BIONICHE LIFE SCIENCES INC.
231 DUNDAS STREET EAST
BELLEVILLE, ONTARIO K8N 1E2
Correspondent:
CHRISTOPHER E. KONDRACKI
1501 WILSON BOULEVARD
SUITE 510
ARLINGTON, VA 22209
Assignment: 13
Reel/Frame:
040271/0859Recorded: 11/09/2016Pages: 6
Conveyance:
RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS).
Assignor:
PALADIN LABS INC.
Exec Dt:
11/04/2016
Assignee:
BIONICHE LIFE SCIENCES INC.
231 DUNDAS STREET EAST
BELLEVILLE, ONTARIO, CANADA K8N1E2
Correspondent:
JILL ANDERFUREN, LEWIS BRISBOIS BISGAARD & SMITH
550 WEST ADAMS STREET
SUITE 300
CHICAGO, IL 60661

Search Results as of: 05/21/2024 09:20 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT